Recce Pharmaceuticals (ASX:RCE) Other Operating Expense : A$12.31 Mil (TTM As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Recce Pharmaceuticals Other Operating Expense?

Recce Pharmaceuticals's Other Operating Expense for the six months ended in Dec. 2023 was A$6.81 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was A$12.31 Mil.

Recce Pharmaceuticals's quarterly Other Operating Expense declined from Dec. 2022 (A$6.51 Mil) to Jun. 2023 (A$5.51 Mil) but then increased from Jun. 2023 (A$5.51 Mil) to Dec. 2023 (A$6.81 Mil).

Recce Pharmaceuticals's annual Other Operating Expense increased from Jun. 2021 (A$7.69 Mil) to Jun. 2022 (A$9.23 Mil) and increased from Jun. 2022 (A$9.23 Mil) to Jun. 2023 (A$12.01 Mil).

Recce Pharmaceuticals Other Operating Expense Historical Data

The historical data trend for Recce Pharmaceuticals's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recce Pharmaceuticals Other Operating Expense Chart

Recce Pharmaceuticals Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Operating Expense

Get a 7-Day Free Trial

1.72

3.67

7.69

9.23

12.01

Recce Pharmaceuticals Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Operating Expense	Get a 7-Day Free Trial											3.71	5.52	6.51	5.51	6.81

Recce Pharmaceuticals Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$12.31 Mil.

Recce Pharmaceuticals Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Recce Pharmaceuticals's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Recce Pharmaceuticals (ASX:RCE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Recce Pharmaceuticals Ltd (ASX:RCE) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

R9Q:Germany

Address

180 George Street, Level 23, Salesforce Tower, Sydney, NSW, AUS, 2000

Website

https://www.recce.com.au

Recce Pharmaceuticals Ltd is an Australia-based globally-focused biotechnology company engaged in the development and commercialization of a new class of antibiotics. It operates in only one business segment being research and development of pharmaceutical drugs. The firm operates in three geographic segments being Australia, the United Kingdom, and the United States of America, of which the majority of the revenue comes from Australia. The company offers antibiotic drugs to treat the diseases caused by various bacterias namely Sepsis, Helicobacter Pylori, Escherichia coli, Pseudomonas aeruginosa, and others.

Recce Pharmaceuticals (ASX:RCE) Headlines

No Headlines